On Tuesday we had the pleasure of meeting Christophe Roos, co-founder of @Euformatics, a company developing NGS analytics. Thanks Christophe for joining our career lunch!
Do you perform Next Generation sequencing? Want to check the quality of your NGS data? Then enrol in our 2021 EQA! For full details see https://t.co/k9qTg6PI53
#NGS@UKNEQAS#quality#data@Euformatics @EMQNOffice
Excellent animation of use of genomics data for healthcare.
It is impossible to achieve without interoperable standards for data access, regulation and technology.
BUT Once all works, positive impact on healthcare e.g. diagnostics is crystal clear.
@ELIXIREurope @B1MG_Project
Do you use Polyphen-2, SIFT, REVEL, GAVIN or ClinPred for interpreting clinical variants? Should you? Are more tools better than one? Some answers in our work using a unique clinically relevant dataset out this week! https://t.co/d2MApD0fwd
The Individual Laboratory Report (ILR) and EQA Summary report for the joint GenQA/EMQN NGS germline/somatic EQAs has been released. Log in to your GenQA account to get your results!
#NGS @EMQNOffice #EQA#proficiencytesting@Euformatics
Introducing the NextSeq™ 2000, our most advanced benchtop sequencer. Explore groundbreaking ideas with higher efficiency, fewer restraints, and more emerging applications.
Learn more: https://t.co/8AE3MaAZX5
#ExperienceNextSeq2000#JPM20#JPMHC20
Ouch.
* Cancer only exome pipelines are unreliable - 69% of somatic mutations are false positives
* 34-80% somatic variants appearing to contribute to intratumor genetic heterogeneity are technical noise